Home Cart Sign in  
Chemical Structure| 1842397-36-7 Chemical Structure| 1842397-36-7

Structure of Ledaborbactam
CAS No.: 1842397-36-7

Chemical Structure| 1842397-36-7

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Synonyms: VNRX-5236

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Ledaborbactam

CAS No. :1842397-36-7
Formula : C12H14BNO5
M.W : 263.05
SMILES Code : O=C(C1=C(OB(O)[C@@H](NC(CC)=O)C2)C2=CC=C1)O
Synonyms :
VNRX-5236

Safety of Ledaborbactam

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
Acquired AmpC-positive Enterobacterales 4 mg/ml 16-20 h To assess the in vitro activity of ceftibuten/VNRX-5236 against acquired AmpC-positive Enterobacterales, results showed at concentrations of 1, 2, and 4 mg/ml, ceftibuten/VNRX-5236 inhibited 70.7%, 81.0%, and 87.9% of isolates, respectively. Antimicrob Agents Chemother. 2022 Jan 18;66(1):e0130421
Serine carbapenemase-positive Enterobacterales 4 mg/ml 16-20 h To assess the in vitro activity of ceftibuten/VNRX-5236 against serine carbapenemase-positive Enterobacterales, results showed at 1 mg/ml concentration, ceftibuten/VNRX-5236 inhibited 75.9% of isolates. Antimicrob Agents Chemother. 2022 Jan 18;66(1):e0130421
ESBL-positive Enterobacterales 4 mg/ml 16-20 h To assess the in vitro activity of ceftibuten/VNRX-5236 against ESBL-positive Enterobacterales, results showed the MIC90 for ceftibuten/VNRX-5236 was ≤0.25 mg/ml, inhibiting 96.5% of isolates at 1 mg/ml concentration. Antimicrob Agents Chemother. 2022 Jan 18;66(1):e0130421
Urinary tract infection isolates of Enterobacterales 4 mg/ml 16-20 h To assess the in vitro activity of ceftibuten/VNRX-5236 against multidrug-resistant Enterobacterales, results showed ceftibuten/VNRX-5236 inhibited 90% of tested isolates (MIC90 at 2 mg/ml). Antimicrob Agents Chemother. 2022 Jan 18;66(1):e0130421

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.80mL

0.76mL

0.38mL

19.01mL

3.80mL

1.90mL

38.02mL

7.60mL

3.80mL

 

Historical Records

Categories